Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study (Q36683621)

15 August 2017

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study (English)

1 reference

15 August 2017

S. H. Goey

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

A. M. Eggermont

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

C. J. Punt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

R. Slingerland

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

J. W. Gratama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

R. Oosterom

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

R. Oskam

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

R. L. Bolhuis

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

G. Stoter

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

19 May 2024

language of work or name

English

0 references

publication date

1 November 1995

1 reference

PMCID

2033917

full work available at URL

15 August 2017

https://www.nature.com/articles/bjc1995501.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

https://europepmc.org/articles/PMC2033917

19 May 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

https://europepmc.org/articles/PMC2033917?pdf=render

19 May 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7577483

http://www.nature.com/articles/bjc1995501.pdf

19 May 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1038/BJC.1995.501

http://www.nature.com/articles/bjc1995501

19 May 2024

1 reference

https://api.crossref.org/works/10.1038/BJC.1995.501

British Journal of Cancer

19 May 2024

published in

1 reference

15 August 2017

72

1 reference

15 August 2017

5

1 reference

15 August 2017

1283-1288

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1995.501

15 August 2017

0 references

cites work

Intrapleural recombinant IL-2 in passive immunotherapy for malignant pleural effusion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Malignant mesothelioma 1982: Review of 4710 published cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Induction of lymphokine-activated killer cells by intrapleural instillations of recombinant interleukin-2 in patients with malignant pleurisy due to lung cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Efficacy of chemoimmunotherapy with cyclophosphamide, interleukin-2 and lymphokine activated killer cells in an intraperitoneal murine tumour model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

The development of new immunotherapies for the treatment of cancer using interleukin-2. A review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Activity of intrapleural recombinant gamma-interferon in malignant mesothelioma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Intrapleural administration of OK432 in cancer patients: Augmentation of autologous tumor killing activity of tumor-associated large granular lymphocytes

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033917

Immunotherapy of murine sarcomas using lymphokine activated killer cells: optimization of the schedule and route of administration of recombinant interleukin-2

5 September 2018

1 reference

12 December 2020

Marked disparity in incidence of bacterial infections in patients with the acquired immunodeficiency syndrome receiving interleukin-2 or interferon-gamma

1 reference

12 December 2020

Intrapleural natural beta interferon in the treatment of malignant pleural effusions

1 reference

12 December 2020

Experience with the use of high-dose interleukin-2 in the treatment of 652 cancer patients

1 reference

12 December 2020

An acquired chemotactic defect in neutrophils from patients receiving interleukin-2 immunotherapy

1 reference

12 December 2020

IL-2-based immunotherapy alters circulating neutrophil Fc receptor expression and chemotaxis

1 reference

12 December 2020

Association of interleukin-2 therapy with staphylococcal bacteremia

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1995.501

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

PMCID

2033917